Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 7Sarcoma 6Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 3Liposarcoma, Myxoid 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Neurofibrosarcoma 2Melanoma 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Carcinoma, Intraductal, Noninfiltrating 2Advanced Refractory Solid Tumors 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thymoma 1Small Cell Lung Cancer Limited Stage 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Myosarcoma 1Lymphatic Metastasis 1Lymphangiosarcoma 1Locally Recurrent Rectal Cancer 1

Interventions

Imatinib Mesylate 4Gemcitabine 2Doxorubicin 2Docetaxel 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2saracatinib 1pembrolizumab 1pazopanib 1envafolimab 1TTI-621 1Sunitinib 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Quality of Life 1Polymerase Chain Reaction 1Neoadjuvant Therapy 1MLN 8237 1Ipilimumab 1Gene Expression Profiling 1Dexrazoxane 1Dactinomycin 1Blotting, Western 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Dermatofibrosarcoma × Radiation Dose Hypofractionation × Clear all
NCT03651375 2021-01-22

UN-RESARC

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Unknown
46 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Lymphangiosarcoma, Myosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡